Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
about
Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptorsAssociation of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritisThe Role of Matrix Metalloproteinase Polymorphisms in Ischemic StrokeOvine-Based Collagen Matrix Dressing: Next-Generation Collagen Dressing for Wound CareThe genetics of sports injuries and athletic performanceHuman stromelysin gene promoter activity is modulated by transcription factor ZBP-89Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domainGenetic determinants of arterial stiffness.Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenomaThe 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.Functional polymorphisms in matrix metalloproteinases -1, -3, -9 and -12 in relation to cervical artery dissectionAllele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaBEvaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice.Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesionsMatrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected femalesGenomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsThe stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate.Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.Ascending thoracic aortic aneurysms protect against myocardial infarctionsCombined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS study.Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya diseaseInteractions between metallopeptidase 3 polymorphism rs679620 and BMI in predicting blood pressure in African-American women with hypertensionMatrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.Large artery stiffness: structural and genetic aspects.Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis.Treatment outcome of chronic low back pain and radiographic lumbar disc degeneration are associated with inflammatory and matrix degrading gene variants: a prospective genetic association study.Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study.The role of matrix metalloproteinases in vascular disease.Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
P2860
Q22010243-40FA34BD-C179-4A59-BAF7-BDC671E5BD86Q24800622-FDFB47F6-3A1C-4A6F-AD8E-07C8EC25FC19Q26741200-33244503-554D-427F-B898-6DE14119EB1FQ26767421-A4408AB3-F06C-4CDF-BEAF-973B37C59D87Q26998923-7D6A0659-C86C-4913-B047-54E251359FF0Q28198820-C76138DA-42A4-4D4E-A54E-6D6A88BA47FBQ28610368-9D1734B5-F680-4588-A3C4-EDE86FB6B03BQ30301168-1A14421E-2429-406D-95A8-5BF2537A90D6Q30427166-2553C07F-FDA1-48AA-81B8-56A523345A37Q33264591-08A22180-B9AB-4641-BC5C-014603F0138EQ33301753-4E1E9FEB-30DB-4057-B172-3A49FA91D1B5Q33491826-66740742-A442-4930-9D7D-B6E7E232DC72Q33548692-B9518EC2-B058-483B-945C-A561972A0A86Q33552910-DF178E34-7BEE-44E7-B139-F1D874502F2FQ33569648-8D36805C-BEA5-43C4-9DD0-0FE6F753159DQ33620544-26CE77F2-0819-408B-BF66-C5354C4C66A7Q33632650-B6955100-ACA3-4679-8F2A-7F0FFCFF289FQ33657480-9AF4EAC3-3AD5-4E86-8E43-EF21CD0C0F17Q33689539-0C6DF611-2C21-42D7-BC4E-E5B83E148485Q33783677-17284C97-A93A-48C5-9769-D5A06D344018Q33936577-4CBBEA9A-A776-4BCE-8326-A1BAC4CB5587Q33952599-5727F0E3-3E61-4BF6-8DE1-64EB7AD9DB39Q34074796-F8C54A70-E199-4374-84C7-8710332C9577Q34098485-947E1858-1411-47ED-BAC3-159CE00C0367Q34103350-01AB7E83-1115-47E7-A857-D32F851C70A4Q34213083-4369030E-32BC-4692-927E-36B7632F8B7BQ34237770-C7D2DA27-F524-4A42-8E30-2FBB11D9DC05Q34281375-C7E1C64F-890E-4A87-8CD2-69ED93754E3BQ34334236-C754E911-D543-4F48-896B-13DA21E8705BQ34423430-1E21BB84-E9AC-491C-B613-C0C2ABE55FE9Q34423714-779F6AA7-8ED2-4E33-A442-345A9530D7D8Q34570436-C077CDF5-5E62-4C52-8106-8374DE904DFFQ34587358-7F6E92B4-6622-4044-9D9C-FD627BDE1B85Q34632871-AECCC5A8-FC43-4549-A19A-94B677A66D72Q34798470-E94BD919-EFA8-47CF-9C62-76CDEB4089A2Q34896489-1C678B10-4BBB-41FB-B2C9-1F41BD6D874CQ34981650-99F212A7-3DB4-4B2E-ACE1-3D9B1EABCF6EQ35075746-50036C78-DAFF-406E-8193-7D0EDF725A16Q35088433-333C6ED9-6068-47AB-8B8B-EF4B0A9190ECQ35114053-637AFCA0-E42C-4BAB-A48B-3E95204F5F17
P2860
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Progression of coronary athero ...... lts in reduced gene expression
@ast
Progression of coronary athero ...... lts in reduced gene expression
@en
Progression of coronary athero ...... lts in reduced gene expression
@nl
type
label
Progression of coronary athero ...... lts in reduced gene expression
@ast
Progression of coronary athero ...... lts in reduced gene expression
@en
Progression of coronary athero ...... lts in reduced gene expression
@nl
prefLabel
Progression of coronary athero ...... lts in reduced gene expression
@ast
Progression of coronary athero ...... lts in reduced gene expression
@en
Progression of coronary athero ...... lts in reduced gene expression
@nl
P2093
P2860
P3181
P1476
Progression of coronary athero ...... lts in reduced gene expression
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.271.22.13055
10.1074/JBC.271.22.13244
P407
P577
1996-05-31T00:00:00Z